Corporate America: Travel Restrictions ‘Harm Our Business’

It's often said that companies saved money on trips not taken during the pandemic — as though they had a choice — and didn't suffer much. But some outcomes show how not traveling can take a toll on operations, revenue generation and due diligence.

Travel restrictions "severely limited" a clinical trial for pharmaceutical company BrainStorm Cell Therapeutics. They mucked up the sales pipeline for metal coating firm AZZ Inc. They "slowed everything down" on M&A for fertility tech company Hamilton Thorne. Gold extractor Dakota Territory Resource Corp. had to delay a stock sale.

The full content is available to subscribers

Jay Campbell

Author: Jay Campbell

Jay Campbell in 2004 created travel business newsletter The Beat, in 2006 co-founded Travel Procurement magazine and in 2010 integrated them with Business Travel News. He served as editorial director until 2013. Jay made his travel industry media debut in 1993 at the Air Travel Journal of Boston while earning his undergraduate degree in journalism at Boston University.
Follow
Notify of
2 Comments
oldest
newest